Zoetis | Omløpsmidler



Current Assets Endring Dato
AbbVie USD 25.58B 2.2B 2024-12
Align Technology USD 2.49B 104.95M 2024-12
Bayer EUR 34.44B 1.31B 2024-12
Bristol-Myers Squibb USD 29.78B 1.7B 2024-12
Charles River Laboratories USD 1.4B 91.65M 2024-12
Dentsply International USD 1.75B 175M 2024-12
Eli Lilly USD 32.74B 1.32B 2024-12
Henry Schein USD 3.98B 164M 2024-12
Idexx Laboratories USD 1.4B 33.85M 2024-12
Illumina USD 2.75B 373M 2024-12
IQVIA Holdings USD 5.83B 197M 2024-12
J&J USD 55.89B 2.64B 2024-12
Laboratory Of America USD 4.81B 103.4M 2024-12
Merck USD 38.78B 1.58B 2024-12
Neogen USD 570.45M 29.8M 2024-11
Pacira USD 745.13M 55.16M 2024-12
Patterson Companies USD 1.84B 4.38M 2025-01
Perrigo USD 2.48B 1.23B 2024-12
Pfizer USD 50.36B 7.14B 2024-12
Quest Diagnostics USD 2.39B 231M 2024-12
Sanofi 30.08B 589M 2024-06
Sanofi 30.08B 589M 2024-06
Zoetis USD 5.99B 296M 2024-12



Zoetis Omløpsmidler - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Mar 2025.